Purchase Order 36C26126P0626

The Department of Veterans Affairs, through Veterans Integrated Service Network 21 (VISN 21), awarded Edwards Lifesciences LLC a $65,000 firm fixed-price purchase order on April 9, 2026, for transcatheter aortic valve replacement (TAVR) surgical implants and related prosthetic devices. The contract, which carries no set-aside designation, will be performed at the VA Palo Alto Health Care System in San Francisco, California, with a completion deadline of July 8, 2026. This procurement supports the VA's mission to provide specialized cardiac surgical care to the veteran population through the supply of advanced cardiovascular medical devices, including TAVR systems and surgical implants that are critical components of modern cardiac surgical programs.

This purchase order is issued under Edwards Lifesciences LLC's broader five-year indefinite delivery contract with VISN 21, valued at $6.5 million and effective through December 31, 2030, which operates on a consignment model for surgical implant services at the VA Palo Alto Health Care System. Edwards Lifesciences LLC, a self-certified small disadvantaged business and subsidiary of Edwards Lifesciences Corporation, is the established sole-source supplier for these specialized transcatheter heart valve technologies to the VA healthcare system. The company's extensive portfolio of federal contracts with the Department of Veterans Affairs reflects its critical role in supplying advanced cardiovascular devices across multiple service networks, with particular procurement volume from VISN 21 and other major service networks including VISN 23 and VISN 17.